Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Jacobs

Showing results (91-100 of 258) with videos related to

Pageof 26
Sort By:
Antimicrobial Agents and Chemotherapy|August 17, 2002
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycinCatherine Clark, Bülent Bozdogan, Mihaela Peric, et al.
Transfusion|September 3, 2011
Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection testMichael R Jacobs, Daniel Smith, W Andrew Heaton, et al.
Journal of the Pediatric Infectious Diseases Society|November 1, 2019
Longitudinal Colonization With Streptococcus pneumoniae During the First Year of Life in a Healthy Newborn CohortSharon B Meropol, Michael R Jacobs, Kurt C Stange, et al.
International Journal of Antimicrobial Agents|January 25, 2005
Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strainsThomas M File, Javier Garau, Michael R Jacobs, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Antimicrobial susceptibility of Streptococcus pneumoniae from children attending day-care centers in a central Italian cityMaria Paola Ronchetti, Rocco Merolla, Saralee Bajaksouzian, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Antipneumococcal activity of BMS 284756 compared to those of six other agentsGlenn A Pankuch, Kensuke Nagai, Todd A Davies, et al.
Infection and Immunity|February 26, 2005
Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniaeDennis O Gor, Xuedong Ding, David E Briles, et al.
Pediatrics|October 5, 2011
Influenza A/H1N1/09-10 infections in a NICU during the 2009-2010 H1N1 pandemicNavin K Vij, Christopher C Stryker, Frank P Esper, et al.
American Journal of Perinatology|March 9, 2012
Staphylococcus aureus, including community-acquired methicillin-resistant S. aureus, in a level III NICU: 2001 to 2008Divya Rana, Nazha Abughali, Deepak Kumar, et al.
Surgical Infections|September 7, 2010
Novel in vitro model for assessing susceptibility of synthetic hernia repair meshes to Staphylococcus aureus infection using green fluorescent protein-labeled bacteria and modern imaging techniquesIhab Halaweish, Karem Harth, Ann-Marie Broome, et al.
Pageof 26

Showing results (91-100 of 258) with videos related to

Sort By:
Pageof 26
Antimicrobial Agents and Chemotherapy|August 17, 2002
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycinCatherine Clark, Bülent Bozdogan, Mihaela Peric, et al.
Transfusion|September 3, 2011
Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection testMichael R Jacobs, Daniel Smith, W Andrew Heaton, et al.
Journal of the Pediatric Infectious Diseases Society|November 1, 2019
Longitudinal Colonization With Streptococcus pneumoniae During the First Year of Life in a Healthy Newborn CohortSharon B Meropol, Michael R Jacobs, Kurt C Stange, et al.
International Journal of Antimicrobial Agents|January 25, 2005
Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strainsThomas M File, Javier Garau, Michael R Jacobs, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Antimicrobial susceptibility of Streptococcus pneumoniae from children attending day-care centers in a central Italian cityMaria Paola Ronchetti, Rocco Merolla, Saralee Bajaksouzian, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Antipneumococcal activity of BMS 284756 compared to those of six other agentsGlenn A Pankuch, Kensuke Nagai, Todd A Davies, et al.
Infection and Immunity|February 26, 2005
Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniaeDennis O Gor, Xuedong Ding, David E Briles, et al.
Pediatrics|October 5, 2011
Influenza A/H1N1/09-10 infections in a NICU during the 2009-2010 H1N1 pandemicNavin K Vij, Christopher C Stryker, Frank P Esper, et al.
American Journal of Perinatology|March 9, 2012
Staphylococcus aureus, including community-acquired methicillin-resistant S. aureus, in a level III NICU: 2001 to 2008Divya Rana, Nazha Abughali, Deepak Kumar, et al.
Surgical Infections|September 7, 2010
Novel in vitro model for assessing susceptibility of synthetic hernia repair meshes to Staphylococcus aureus infection using green fluorescent protein-labeled bacteria and modern imaging techniquesIhab Halaweish, Karem Harth, Ann-Marie Broome, et al.
Pageof 26